Background and Aims: Stroke is the second leading cause of death worldwide. Approximately 82-92% of all strokes are ischemic (IS). The goal of this study is enhancing management of acute IS based on ESO-EAST (Enhancing and Accelerating Stroke Treatment) RES-Q (Registry of Stroke Care Quality) data. The first goal of this study was to measure the current quality of stroke care to define the differences between countries and hospitals in a country level. Azerbaijan is participated in this project from 2017. 
Methods: We analyzed data collected in RES-Q for March 2018. 101 patients (43.56% men, 56.44% women) from six hospitals were involved to the research during study period. 67 of them (66.34% of all strokes) have experienced IS. The statistical analysis of data was performed centrally.
Results: Brain CT/MRI was performed for 98.95% of patients, in 62.77% cases – within an hour after the onset of first symptoms. However, only 4.48% of patients treated with rTPA. Carotid artery imaging was performed for 54.41% of patients. 29.17% of patients had 50-70% stenosis, 5.56% more than 70% stenosis. Antihypertensive treatment was prescribed in 97.78% cases. 73.97% of patients took antiplatelets, 17.81% Vit. K antagonists, 2.74% dabigatran. 71.43% of patients with atrial fibrillation took anticoagulants. Statins were prescribed in 66.67% cases.
Conclusions: Considering the fact, that very low percentage of patients was treated with intravenous thrombolysis, despite the early brain imaging was performed should be increased awareness for the management of acute IS. Establishment of stroke units will have a crucial role in acute stroke management in Azerbaijan.

TREATMENT OF ISCHEMIC STROKE IN AZERBAIJAN: FIRST ANALYSIS OF ESO-EAST AND RES-Q REGISTRY